| Biological products: cellular therapy and FDA approved products A Golchin, TZ Farahany Stem cell reviews and reports 15 (2), 166-175, 2019 | 185 | 2019 |
| The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review A Golchin, TZ Farahany, A Khojasteh, F Soleimanifar, A Ardeshirylajimi Current stem cell research & therapy 14 (1), 22-33, 2019 | 162 | 2019 |
| Enzymatic antioxidant and lipid peroxidation evaluation in the newly diagnosed breast cancer patients in Iran P Kangari, TZ Farahany, A Golchin, S Ebadollahzadeh, A Salmaninejad, ... Asian Pacific journal of cancer prevention: APJCP 19 (12), 3511, 2018 | 61 | 2018 |
| Relationship between preoperative serum CA15-3 and CEA levels and clinicopathological parameters in breast cancer N Moazzezy, TZ Farahany, M Oloomi, S Bouzari Asian Pacific journal of cancer prevention 15 (4), 1685-1688, 2014 | 45 | 2014 |
| Generation of anti-SN38 antibody for loading efficacy and therapeutic monitoring of SN38-containing therapeutics TZ Farahani, MR Nejadmoghaddam, S Sari, R Ghahremanzadeh, ... Heliyon 10 (12), 2024 | 1 | 2024 |
Ali GolchinPh.D of applied cell sciences. School of Medicine, Urmia University of Medical SciencesVerified email at umsu.ac.ir